Patents by Inventor Stella Rudkjær Rasmussen

Stella Rudkjær Rasmussen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Formulation Comprising Metformin and Repaglinide
    Publication number: 20140066482
    Abstract: The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 6, 2014
    Applicant: Novo Nordisk A/S
    Inventors: Bent Hoejgaard, Breian Knudsen, Stella Rudkjaer Rasmussen, Lene Orup Jacobsen
  • Pharmaceutical Formulation Comprising Metformin and Repaglinide
    Publication number: 20110294852
    Abstract: The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.
    Type: Application
    Filed: August 9, 2011
    Publication date: December 1, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Bent Højgaard, Breian Knudsen, Stella Rudkjær Rasmussen, Lene Orup Jacobsen
  • Pharmaceutical Formulation Comprising Metformin and Repaglinide
    Publication number: 20100029721
    Abstract: The invention is related to a pharmaceutical composition comprising repaglinide in combination with metformin or a salt thereof in unit dosage form wherein a pre-formulation of the repaglinide has a pH independent dissolution profile and a relative humidity of less than about 25% prior to mixing with the metformin or a salt thereof; and optionally one or more pharmaceutically acceptable excipients and to a method for its preparation.
    Type: Application
    Filed: September 28, 2007
    Publication date: February 4, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Bent Hojgaard, Breian Knudsen, Stella Rudkjaer Rasmussen, Lene Orup Jacobsen
  • Stable pharmaceutical formulation
    Patent number: 6525084
    Abstract: This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the granulation process such that a more stable formulation is obtained.
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: February 25, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Stella Rudkjær Rasmussen, Per Grønlund
  • STABLE PHARMACEUTICAL FORMULATION
    Publication number: 20020022649
    Abstract: This invention relates to a novel granulate and a novel oral solid dosage formulation, each comprising an active ingredient and one or more carriers prepared by a novel wet granulation method. This method provides that the mixture of active ingredient and carrier be kept below 40° C. during the granulation process such that a more stable formulation is obtained.
    Type: Application
    Filed: July 21, 1999
    Publication date: February 21, 2002
    Inventors: STELLA RUDKJAER RASMUSSEN, PER GRONLUND